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Serological and polymerase chain reaction (PCR)-based studies
have shown that human herpesvirus-8 (HHV-8) infection is infre-
quent in the general population of the UK and the USA, but
common in groups at increased risk for Kaposi’s sarcoma (KS)
such as HIV-infected homosexual men (Gao et al, 1996; Kedes
et al, 1996; Lennette et al, 1996; Simpson et al, 1996). Antibodies
to HHV-8 are detected more frequently in sexually transmitted
disease (STD) clinic attendees than in blood donors, suggesting
that HHV-8 may be sexually transmitted (Kedes et al, 1996;
Simpson et al, 1996). Direct evidence for homosexual transmis-
sion of HHV-8 has been reported (Martin et al, 1998; Melbye et al,
1998; Renwick et al, 1998; Smith et al, 1999). Evidence for trans-
mission via heterosexual contact, however, is less consistent. A
large study of risk factors for HHV-8 infection in South African
cancer patients found that the risk of HHV-8 infection was associ-
ated with increased numbers of sexual partners (Sitas et al, 1999).
A study of STD clinic attendees in London, however, found no
evidence for sexual transmission in heterosexuals, including those
born in Africa (Smith et al, 1999). HHV-8 infection does not occur
in children in the UK (Simpson et al, 1996), and in the US occurs
rarely, after puberty (Blauvelt et al, 1997), as would be expected
for a sexually transmitted virus.
HHV-8 infection has been shown to be more common in adult
blood donors from geographical areas which have an elevated
incidence of classic KS, such as Italy and Greece (Calabro et al,
1998; Rezza et al, 1998; Whitby and Boshoff, 1998; Whitby et al,
1998), or African endemic KS (Gao et al, 1996; Lennette et al,
1996; Simpson et al, 1996; Mayama et al, 1998; Olsen et al, 1998).
In Italy, where marked regional variation occurs in the incidence
of KS (Geddes et al, 1994, 1995), HHV-8 prevalence has been
shown to mirror KS incidence, being significantly higher in the
south than the north (Calabro et al, 1998; Whitby et al, 1998).
KS occurs in children in Africa (Ziegler and Katongole-Mbidde,
1996) and HHV-8 infection in African children has been reported
(Kasolo et al, 1997; Bourboulia et al, 1998; Mayama et al, 1998;
Andreoni et al, 1999). One report provided evidence that HHV-8
infection in African children may be transmitted from mother to
child (Bourboulia et al, 1998). Prevalence of HHV-8 in African
children increases with age even before puberty (Bourboulia et al,
1998; Mayama et al, 1998; Andreoni et al, 1999), indicating that
non-sexual horizontal transmission of the virus occurs. Detection
of antibodies to HHV-8 in a small study of Ugandan children
suggested an association between HHV-8 and hepatitis B infec-
tion, indicating that transmission of HHV-8 in childhood is associ-
ated with living conditions which may also facilitate infection with
hepatitis B virus (Mayama et al, 1998). Childhood KS does not
occur in regions with a high incidence of classic KS such as Italy
and Greece. The prevalence of HHV-8 in children from non-
African regions with a high incidence of classic KS and a high
prevalence of HHV-8 in the adult population, is not known. Here
we report on the prevalence of HHV-8 in children in Italy.
MATERIALS AND METHODS
We investigated the prevalence of antibodies to HHV-8 in 567
hospitalized children (306 male, 261 female) from three different
regions of Italy, including 388 children from Modena, Emilia-
Romagna (lower Po valley, Northern Italy), 76 from Brindisi and
Bari, Apulia (Southeastern Italy) and 103 children from Palermo,
Sicily (Southern Italy). Sera were collected from consecutive chil-
dren admitted to the Departments of Pediatrics at each site. The
vast majority were admitted for a single day and were being
treated for minor childhood complaints. All children included in
the study were seronegative for HIV-1, hepatitis B virus (HBV),
HCV and Treponema pallidum, and did not have KS. Antibodies
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to the HHV-8 latent nuclear antigen (LNA-1) were detected by
an immunofluorescence assay (IFA) using a HHV-8 infected
peripheral effusion lymphoma (PEL) cell line, BCP-1 (Gao et al,
1996; Boshoff et al, 1998). LNA-1 IFA is the most sensitive and
specific assay currently available to reveal past or present infec-
tion with HHV-8 (Rabkin et al, 1998). Sera were tested in a
blinded manner at a dilution of 1:100, as previously described
(Simpson et al, 1996; Whitby et al, 1998).
RESULTS
The results of the serological survey are summarized in Table 1.
The prevalence of antibodies against HHV-8 LNA-1 in Italian
children was 4.4%. HHV-8 seroprevalence was 4.1% in Northern
Italy (the Po valley) and 5% in Southern Italy (Apulia and Sicily),
which is not significantly different (P = 0.66, Fisher’s exact test).
There was no significant difference in HHV-8 antibody prevalence
between males and females (14/306, 4.6%, males; 11/261, 4.2%
females, P = 1.00 c2 test). Information on age was available for
children from the Po valley (Table 2). Of 57 infants (< 1 year), two
(3.5%) had antibodies to HHV-8 (6 and 9 months old respec-
tively). It is possible that maternal antibodies to HHV-8 were
detected in these infants. A similar seroprevalence rate (3.6%) was
detected in children aged 1 and 2 years. Antibodies to HHV-8 were
detected in only one of 90 children aged 3–5 years (1.1%).
Seroprevalence rates increased in children aged 6–10 years (6.3%)
and 11–15 years (7.8%) respectively. Children aged 6 and over
have a 160% increased chance of being positive compared to
younger children (odds ratio 2.60, 95% confidence interval (CI)
0.95–7.5, P = 0.06).
DISCUSSION
The results of our study show that HHV-8 infection occurs in
Italian children before puberty suggesting that non-sexual routes
of transmission of HHV-8 are important in a country with a
relatively high seroprevalence rate in the adult population.
Vaccination to HBV was introduced into Italy several years ago. It
is therefore not possible to investigate in this study whether factors
facilitating HBV transmission also play a role in the transmission
of HHV-8 as has been suggested in Uganda (Mayama et al, 1998).
However, crowded living conditions and poor hygiene associated
with HBV transmission in Africa are not found in Italy and there-
fore may not play a major role in HHV-8 transmission.
While in adult blood donors the presence of antibodies to HHV-
8 is significantly higher in Southern than in North/Central Italy
(Calabro et al, 1998; Whitby et al, 1998), in children HHV-8
seroprevalence rates show no differences between the regions
surveyed. The numbers studied were low, however, so it is
possible that real differences exist and could be demonstrated in a
larger study. Whilst seroprevalence increases with age in children
from the Po valley, especially in those aged 6–10 years, it remains
lower than in adults. In contrast, seroprevalence in Ugandan
children is reported to reach adult levels before puberty (Mayama
et al, 1998). Overall, these findings suggest that risk factors for
HHV-8 transmission differ between children and adults and that in
Italy, marked regional differences occur in the risk factors
affecting adults more than children.
Clustering of HHV-8 seroprevalence rates have been docu-
mented in spouses, children and siblings of patients with classic
KS from Sardinia, Italy, suggesting the occurrence of intrafamilial,
horizontal or vertical transmission (Angeloni et al, 1998). Further
studies are needed to determine the routes of transmission of
HHV-8 in children. HHV-8 has been detected in the saliva of
HIV-infected KS patients (Koelle et al, 1997; Vieira et al, 1997),
indicating one possible source of virus; however, studies in
immunocompetent HHV-8 positive individuals have yet to be
reported.
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